



Dental implantation currently 
occupies one of the main places 
in the treatment of dental patients 
with various types of defects in 
dentures. Annually approximately 
6 million implants are installed 
around the world [1, 2]. In this 
regard, the issue of improving 
the quality of dental implantation 
and prevention of complications 
acquire special significance. It is 
known that the successful implant 
integration is affected by the sur-
gery technique, the condition of 
bone tissue, neurohormonal and 
immune homeostasis, the plaque 
microflora pathogenicity, the gen-
eral reaction of the organism [3, 4]. 
Peri-implant mucositis is 
defined as mucosa inf lamma-
tion around the dental implant 
cervix. Peri-implantitis is bone 
inflammation around the oste-
ointegrated implant, which can 
lead to implant rejection and 
subsequent long and expensive 
restorative treatment [5]. Accord-
ing to clinical surveys, peri-im-
plantitis develops in 12–43 % of 
cases, mucositis – in 60–80 % of 
patients with dental implants. 
Symptoms of inflammation can 
occur both immediately after the 
implantation, and in the long 
run (in many months or even 
years) [6]. There is no reliable 
data indicating which treatment 
(therapeutic, surgical) may be 
most effective in these diseases. 
Peri-implantitis is a complex dis-
ease that is difficult to treat and 
is constantly returning to the 
stage of recurrence. At treatment 
more than one year it is possible to speak about the chronic 
disease [7]. For a successful long-term treatment of mucositis 
and peri-implantitis, an integrated approach is required where 
an important place is given to the control of dental plaques and 
oral hygiene, both periodontal and dental implantation [8].
The universal regulatory function is performed by immune 
system mediators – cytokines (interleukins – IL). IL-17 is clas-
sified as inflammatory cytokine due to its ability to induce the 
expression of many inflammatory mediators, especially those 
involved in proliferation, ripening, and chemotaxis of neutro-
phils. Its main function is the induction of IL-6, IL-8 synthesis 
and, with this, involvement of other cells into the inflammation 
focus. The biological role of IL-6 is to induce inflammatory 
mechanisms and activate immune protection (activation and 
differentiation of T cells, ripening of B cells, increased hemo-
poiesis). IL-6 is the main inductor of the final stage of the im-
mune response. IL-8 is one of the most important chemokines 
involved in the regulation of the early inflammatory response 
(the neutrophils’ function) and helps to determine the type 
of further immune response. It 
is synthesized mainly by mono-
cytes/macrophages, lymphocy- 
tes, fibroblasts, epithelial and en-
dothelial cells [9, 10]. 
It is quite difficult to recog-
nize the complications develop-
ment at the early stages of the 
disease [11]. The pain and swell-
ing of the soft tissues after im-
plantation are always present, as 
the tissue injured in the course of 
surgical intervention doesn’t heal 
instantly. The healing process 
lasts no more than a week in the 
absence of any complications. A 
meaningful answer to the ques-
tion of adequate algorithm for 
assessing the condition of the cy-
tokine system in blood serum in 
dynamics at dental implantation 
was not found in the available 
literature.
The purpose of this research 
is to determine the functional 
condition of the cytokine system 
in blood serum at dental implan-
tation in order to improve the 
early diagnosis of inflammatory 
complications.
The research aim: to find out 
the features of immunological 
parameters changes in periph-
eral blood at mucositis, peri-im-
plantitis in dynamics.
2. Material and Methods
The patients were on treat-
ment in the department of max-
illofacial surgery of Lviv Emer-
gency Hospital and the Dental 
Medical Center Danylo Halytsky 
Lviv National Medical University 
for the period of 2014–2016.
41 patients before dental implantation and on the 5th, 
9th day after surgical intervention have been examined. All 
patients were practically healthy. Among them – 23 men and 
18 women aged 29 to 56 years. Depending on the nosological 
nature of the inflammatory complications that arose in the 
peri-implant zone at the initial stage, the patients were divided 
into two groups: 1st – 14 patients with dental mucositis, 2nd – 
12 patients with dental peri-implantitis of the I-II degree. The 
control group consisted of 15 patients who had no inflammatory 
complications. Clinical-radiological, laboratory examination 
has been made to all patients.
The level of IL-6, IL-8 and IL-17 in blood serum was defined 
by applying enzyme multiplied immunoassay using the set of 
chemical agents and following the instructions set by the “Dia-
clone” producer (France).
The research results are shown as arithmetic average values 
and standard deviations (M±m). t Student criteria were applied 
for estimating possible differences between the two groups. 
Main calculations were made in Excel 2013. 
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with dental implants. The universal regulatory function is 
performed by immune system mediators – cytokines (inter-
leukins – IL). The purpose of this research is to determine 
the functional condition of the cytokine system in blood 
serum at dental implantation in order to improve the early 
diagnosis of inflammatory complications. The research aim: 
to find out the features of immunological parameters changes 
in peripheral blood at mucositis, peri-implantitis in dynam-
ics. Depending on the nosological nature of the inflamma-
tory complications that arose in the peri-implant zone at 
the initial stage, the patients were divided into two groups: 
1st – 14 patients with dental mucositis, 2nd – 12 patients with 
dental peri-implantitis of the I–II degree. The control group 
consisted of 15 patients who had no inflammatory compli-
cations.The level of IL-6, IL-8 and IL-17 in blood serum was 
defined by applying enzyme multiplied immunoassay using 
the set of chemical agents “Diaclone”. There were no probable 
changes in the cytokines system with mucositis. The obtained 
results of laboratory and clinical studies indicate that dental 
peri-implantitis features with decrease in IL-6, increase in IL-
8, IL-17 levels. That is why implantation requires thorough 
preliminary diagnostics, namely determination of patients' 
cytokine status. Assessment of the functional condition of 
the body cytokines system may be important for determining 
the strategy of dental implantation and prevention of early 
postoperative complications.
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3. Results
After the dental implantation surgical phase patients showed 
various relevant local reactions to surgical trauma. Clinical 
signs of the local reaction: pain, mucosa swelling and hyper-
emia, fibrinous pellicle on the suture line – found in patients of 
all groups. Local inflammation symptoms disappeared in the 
majority of control patients on the 5.6±0.6 day after the implan-
tation. In this period, the mucosa became pale pink in color, the 
wound edges were adjacent to each other, their contours were 
even and clean, there was no pain and bleeding when palpation 
of the surgical area. Peri-implantitis is hard to differentiate 
from mucositis at the early stages after the implantation in case 
of appearance of the oral cavity acute inflammation signs. In 
patients of the 1st and 2nd comparison group unequal severity of 
edema, hyperemia, pain in the operation sites have been noted 
on the 5th day after the implantation. Thus, half of the patients 
demonstrated the maximum intensity of these signs manifesta-
tion; while the rest showed only their slight decrease. Regression 
of inflammatory phenomena in patients of the 1st group took 
place on the 9th day. Patients of the 2nd group demonstrated sig-
nificant swelling and rubor of the soft tissues surrounding the 
implant, severe pain in the area of artificial root implantation, 
gums bleeding, the appearance of pockets in the gums tissues, 
formation of fistulas in the area adjacent to the implant with 
exudates and pyorrhea, fever. 
Indicators of levels of IL-6, IL-8, IL-17 of the patients in the 
control group are presented in Table 1–3.
Table 1
The level of IL-6 in blood serum of patients with dental 
mucositis and dental peri-implantitis (ng/l)
Research groups 
Research terms 
the 1st day the 5th day the 9th day 
Control rate 5.8±0.4 5.8±0.4 5.8±0.4
The 1st group 6.2±0.3 6.6±0.2* 6.3±0.3
The 2nd group 13.6±0.2*,** 22.4±0.2*,** 26.4±0.3*,** 
Note: * – Р<0.05 as compared to the control rate; ** – Р<0.05 as compared 
to the 1st group
In the 1st group there was no significant change in the level 
of IL-6 in comparison with the control group. On the 1st day in 
the 2nd group the level of IL-6 was by 2.3 times higher than in 
the control group and twice as much as in the 1st group. Increase 
in the level of IL-6 was until the 9th day. 
Table 2
The level of IL-8 in blood serum of patients with dental 
mucositis and dental peri-implantitis (ng/l)
Research groups 
Research terms 
the 1st day the 5th day the 9th day 
Control rate 2.0±0.2 2.0±0.2 2.0±0.2
The 1st group 5.3±0.2* 3.2±0.6 2.8±0.4
The 2nd group 19.6±0.2*,** 16.4±0.4*,** 13.2±0.3*,** 
Note: * – Р<0.05 as compared to the control rate; ** – Р<0.05 as compared 
to the 1st group
The highest level of IL-8 (by 9.8 times as compared to the 
control group) on the 1st day was recorded in the 2nd group, 
which corresponded to the maximum activation of the im-
mune cells in the inf lammatory focus and allows predicting 
the development of the peri-implantitis. During the 9-days 
period there was a tendency to decrease of IL-8 content but 
in the 2nd group the level remained significantly higher by 
6.6 times as to the control group and by 4.7 times than in 
the 1st group. 
Table 3
The level of IL-17 in blood serum of patients with dental 
mucositis and dental peri-implantitis (ng/l)
Research groups 
Research terms 
the 1st day the 5th day the 9th day 
Control rate 2.2±0.8 2.2±0.8 2.2±0.8
The 1st group 5.6±0.2* 4.6±0.2* 3.1±0.2
The 2nd group 14.5±0.4*,** 10.2±0.3*,** 8.3±0.2*,** 
Note: * – Р<0.05 as compared to the control rate; ** – Р<0.05 as compared 
to the 1st group
The patients demonstrated the increase in IL-17 con-
centration before the surgical intervention, which indicated 
pronounced inflammatory process. The 1st group patients 
manifested decrease in the pain intensity, improvement of the 
general-somatic condition on the 9th day. The content of IL-17 
decreased by 1.8 times when compared with its level on the first 
day but remained above the control group by 4 times. High level 
of IL-17 further preserved on the 9th day in the 2nd group indi-
cating pronounced inflammatory process.
4. Discussion 
It has been shown that when IL-17 level decreases, IL-8 
production decreases and IL-6 production increases, indicating 
cytokine disregulation and determines the complicated clinical 
course. The obtained data confirm high sensitivity of interleuk-
ins as inflammation markers. 
The inf lammatory process of the patients with mucositis 
was accompanied by catarrhal phenomena on the 9th day. 
Chronic inf lammation of the peri-implant cuff mucosa, 
congestive hyperemia and edema have been noted. There was 
no pain. Hypertrophic phenomena prevailed in the clinical 
aspect of another part of the patients. Patients complained 
of unusual appearance of gum, their growth, bleeding, pain 
when eating solid food. There was the increase in the gingival 
papilla at the teeth adjacent to the implant and the gingival 
margin of the peri-implant cuff, the mucosa of which some-
times expanded to such an extent that it partially closed the 
implants crowns, forming cavities containing food residues, 
dental plaque. No pathological changes were detected on 
radiograph. There were no probable changes in the cyto-
kines system with mucositis. In the absence of timely and 
adequate treatment, the spread of inf lammation from the 
tissue cuff to the bone tissue surrounding the implant and 
the development of the peri-implantitis is possible. Patients 
with peri-implantitis complained of pain in the implant area. 
At objective examination: presence of edema and hyperemia 
of the peri-implant gum, serous and purulent discharge, the 
presence of granulations and peri-implant pocket, mobility 
of the implant of varying degrees. The radiograph demon-
strated destruction of bone tissue.
It has been revealed that one of the main factors of the 
increased risk of dental peri-implantitis is cytokine system 
imbalance.
The obtained results of laboratory and clinical studies indi-
cate that dental peri-implantitis features with decrease in IL-6, 
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increase in IL-8, IL-17 levels. That is why implantation requires 
thorough preliminary diagnostics, namely determination of 
patients’ cytokine status.
Thus, the results of the research carried out substantially 
complement the idea of the etiology of dental mucositis and 
dental peri-implantitis. 
Assessment of the functional condition of the body cyto-
kines system may be important for determining the strategy 
of dental implantation and prevention of early postoperative 
complications. Further researches will determine the scheme 
of complex therapy of peri-implant tissues diseases, which 
includes monitoring the immunological condition of patients.
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